181 related articles for article (PubMed ID: 35440702)
1. Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanisms.
Chen S; Chen X; Li Z; Mao J; Jiang W; Zhu Z; Li Y; Jiang Z; Zhao W; Tan G; Wang Z
Sci Rep; 2022 Apr; 12(1):6445. PubMed ID: 35440702
[TBL] [Abstract][Full Text] [Related]
2. USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.
Chandrasekaran AP; Kaushal K; Park CH; Kim KS; Ramakrishna S
Theranostics; 2021; 11(20):9752-9771. PubMed ID: 34815782
[No Abstract] [Full Text] [Related]
3. USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers.
Akhavantabasi S; Akman HB; Sapmaz A; Keller J; Petty EM; Erson AE
Mamm Genome; 2010 Aug; 21(7-8):388-97. PubMed ID: 20549504
[TBL] [Abstract][Full Text] [Related]
4. Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms.
Zhang Y; Xia Q; Lin J
Oncol Rep; 2018 Aug; 40(2):715-725. PubMed ID: 29901201
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
6. USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2.
Dou N; Hu Q; Li L; Wu Q; Li Y; Gao Y
Int J Biol Sci; 2020; 16(9):1648-1657. PubMed ID: 32226309
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1.
Nakae A; Kodama M; Okamoto T; Tokunaga M; Shimura H; Hashimoto K; Sawada K; Kodama T; Copeland NG; Jenkins NA; Kimura T
Biochem Biophys Res Commun; 2021 May; 552():120-127. PubMed ID: 33744759
[TBL] [Abstract][Full Text] [Related]
8. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
[TBL] [Abstract][Full Text] [Related]
9. USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target.
Li S; Song Y; Wang K; Liu G; Dong X; Yang F; Chen G; Cao C; Zhang H; Wang M; Li Y; Zeng T; Liu C; Li B
Cell Death Discov; 2023 Sep; 9(1):338. PubMed ID: 37679322
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
[TBL] [Abstract][Full Text] [Related]
12. USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration.
Wang Y; Zhou D; Kong Y; Yang Q; Ding Y; Wang W
Biomed Res Int; 2022; 2022():6109052. PubMed ID: 36582601
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer.
Hu W; Wei H; Li K; Li P; Lin J; Feng R
Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28597490
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive RNA-sequencing transcriptome profiling.
Ahir BK; Lakka SS
Cell Signal; 2019 Jan; 53():22-38. PubMed ID: 30244172
[TBL] [Abstract][Full Text] [Related]
15. High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma.
Xiu M; Bao W; Wang J; Chen J; Li Y; Hai Y
BMC Cancer; 2023 Nov; 23(1):1105. PubMed ID: 37957631
[TBL] [Abstract][Full Text] [Related]
16. circRNA derived from CLSPN (circCLSPN) is an oncogene in human glioblastoma multiforme by regulating cell growth, migration and invasion via ceRNA pathway.
Hu T; Lei D; Zhou J; Zhang BO
J Biosci; 2021; 46():. PubMed ID: 34269180
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
18. Identification of UGP2 as a progression marker that promotes cell growth and motility in human glioma.
Zeng C; Xing W; Liu Y
J Cell Biochem; 2019 Aug; 120(8):12489-12499. PubMed ID: 30816613
[TBL] [Abstract][Full Text] [Related]
19. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
20. ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling.
Chen X; Huang L; Yang Y; Chen S; Sun J; Ma C; Xie J; Song Y; Yang J
Aging (Albany NY); 2020 Jan; 12(1):224-241. PubMed ID: 31905171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
